Tomoyasu Jo

17PUBLICATIONS
61CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 29, 2026
Usefulness of pegfilgrastim for allogeneic peripheral blood stem cell collection from healthy donors.

|Apr 28, 2026
Impact of CD34+ cell dose on outcomes of related allogeneic PBSCT in adult AML patients.

|Apr 15, 2026
Decreased renal function predicts severe cytokine release syndrome after CAR-T-cell therapy for large B-cell lymphoma.

|Nov 17, 2025
Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

Yusuke Tashiro, Tomoyasu Jo, Toshio Kitawaki

|Oct 20, 2025
Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCT.

Tomotaka Suzuki, Tomoyasu Jo, Kota Yoshifuji

|Aug 11, 2025
Prolonged chimeric antigen receptor-T apheresis to infusion time is associated with inferior outcomes in diffuse large B-cell lymphoma.

Suguru Morimoto, Tomoyasu Jo, Toshio Kitawaki

Pageof 3

Frequent Collaborators

14 joint publications

Yasuyuki Arai

8 joint publications

Junya Kanda

6 joint publications

Momoko Nishikori

5 joint publications

Toshio Kitawaki